Recurrence of Thromboembolic Venous Disease of Atypical Location (RUSE)

Recurrence of Thromboembolic Venous Disease of Atypical Location

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06815874

Acronym

RUSE

Enrollment

300

Registered

2025-02-10

Start date

2024-12-01

Completion date

2025-02-28

Last updated

2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thromboembolism

Brief summary

RUSE is a retrospective data-based study designed to assess the frequency, characteristics and phenotype of documented recurrences of thromboembolic venous disease in atypical locations.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* All patients over 18, * Affiliated to sécurité sociale * Having at least one episode of atypical localisation of VTE at Brest University Hospital

Exclusion criteria

* Patients under legal protection * Minors * Refusal to participate

Design outcomes

Primary

Measure	Time frame	Description
Documented recurrence after previous VTE in atypical localisations	01/01/2005 to 01/11/2024	All forms of VTE of typical (DVT and PE) and atypical location, muscular venous thrombosis and documented superficial venous thrombosis

Countries

France

Outcome results